In this review, we demonstrate the role played by Akt (also known as Protein Kinase B) in the progression of HCC at the level of the tumor and TME and the growing interest in targeting Akt as a therapeutic option for HCC, Figure 1. Here, AKT1 is linked to hepatocellular carcinoma.